Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type

BACKGROUND: Nucleolin expressed at the cell surface is a binding protein for a variety of ligands implicated in tumorigenesis and angiogenesis. By using a specific antagonist that binds the C-terminal RGG domain of nucleolin, the HB-19 pseudopeptide, we recently reported that targeting surface nucle...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Krust, Bernard, El Khoury, Diala, Nondier, Isabelle, Soundaramourty, Calaiselvy, Hovanessian, Ara G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3199867/
https://ncbi.nlm.nih.gov/pubmed/21812966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-333
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak